MyoKardia
MYOK
MYOK was delisted on the 16th of November, 2020.
115 hedge funds and large institutions have $974M invested in MyoKardia in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 9 closing their positions.
520% more capital inflows, than outflows
Capital inflows: $305M | Capital outflows: $49.2M
444% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 9
81% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 21
53% more funds holding
Funds holding: 75 → 115 (+40)
15.64% more ownership
Funds ownership: 48.43% → 64.06% (+16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
+$34.6M |
| 2 |
EcoR1 Capital
San Francisco,
California
|
+$22M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.6M |
| 4 |
D.E. Shaw & Co
New York
|
+$18.8M |
| 5 |
BlackRock
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.1M |
| 2 |
JP Morgan Chase
New York
|
-$10M |
| 3 |
Millennium Management
New York
|
-$7.12M |
| 4 |
Marshall Wace North America
New York
|
-$4.46M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.75M |
MYOK Hedge Fund Activity: Q3 2017 in Review
115 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in MyoKardia (MYOK) for Q3 2017, worth a combined $974M — up 371% from $207M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new MYOK positions and 9 closed out — a net gain of 40 holders — while 38 added to existing stakes and 21 trimmed.
The largest buyer was Deerfield Management, adding an estimated $34.6M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.
- 115 institutional investors held MyoKardia (MYOK) as of Q3 2017, up from 75 in Q2 2017.
- Funds reported $974M of MyoKardia stock for Q3 2017, up 371% quarter-over-quarter.
- 49 funds opened new MyoKardia positions in Q3 2017 and 9 closed out, a net change of +40 holders.
- The largest MyoKardia buyer in Q3 2017 was Deerfield Management, an estimated $34.6M added.
- The largest MyoKardia seller in Q3 2017 was Fidelity Investments, an estimated $16.1M sold.
Based on aggregated 13F filings for Q3 2017.